Table 1.
Patients’ general characteristics and body composition indices (n = 269).
| Patients’ general characteristics | |
|---|---|
| Sex | |
| Male | 208 (77.30) |
| Female | 61 (22.70) |
| Age at diagnosis (years) | 66.41±11.46 |
| Height (cm) | 161.63±8.23 |
| Weight (kg) | 64.23±11.66 |
| BMI (kg/m2) | 24.49±3.52 |
| Smoking | |
| Yes | 100 (37.2) |
| No | 169 (62.8) |
| Hypertension | |
| Yes | 147 (54.6) |
| No | 122 (45.4) |
| Diabetes mellitus | |
| Yes | 58 (21.6) |
| No | 211 (78.4) |
| ECOG | |
| 0 | 191 (71.0) |
| 1 | 69 (25.7) |
| 2 | 9 (3.3) |
| Sarcopenia | |
| Yes | 80 (29.70) |
| No | 188 (69.90) |
| Missing | 1 (0.4) |
| Obesity | |
| Yes | 53 (19.7) |
| No | 216 (80.3) |
| Tumor-related parameters | |
| Cancer stage | |
| Tis | 12 (4.5) |
| Ta | 120 (44.6) |
| T1 | 137 (50.9) |
| Type of histology | |
| Low grade | 68 (25.3) |
| High grade | 190 (70.6) |
| Unknown | 11 (4.1) |
| Tumor number | |
| Single | 118 (43.9) |
| Multiple | 151 (56.1) |
| Cancer other than BC and UTUC | |
| Yes, before BC | 13 (4.8) |
| Yes, after BC | 38 (14.1) |
| No | 213 (79.2) |
| Unknown | 5 (1.9) |
| Recurrence | |
| Yes | 111 (41.3) |
| No | 158 (58.7) |
| Progression | |
| Yes | 68 (25.3) |
| No | 201 (74.7) |
| Survival status | |
| Alive | 170 (63.2) |
| Dead | 99 (36.8) |
| BCG IVI (times) | 10.7±5.1 |
| Area | |
| SAT (cm2) | 115.9±49.7 [14.7 to 327.3] |
| VAT (cm2) | 139.8±70.4 [4.3 to 415.2] |
| MUSCLE (cm2) | 120.4±27.2 [64.1 to 200.3] |
| PARA (cm2) | 48.5±11.6 [15.3 to 80.0] |
| PSOAS (cm2) | 14.5±4.9 [5.6 to 28.9] |
| Height adjustment index | |
| SAT (HU) | 44.7±19.6 [6.5 to 131.1] |
| VAT (HU) | 53.4±26.4 [1.7 to 152.5] |
| MUSCLE (HU) | 45.8±8.6 [26.5 to 75.4] |
| PARA (HU) | 18.5±3.8 [6.8 to 29.3] |
| PSOAS (HU) | 5.5±1.7 [2.1 to 12.1] |
| Radiation attenuation | |
| SAT | −113.7±106.2 [−1425.7 to −31.0] |
| VAT | −95.2±11.0 [−163 to [−52] |
| MUSCLE | 31.5±9.0 [−8.05 to 48.2] |
| PARA | 34.5±10.3 [−15 to 51.7] |
| PSOAS | 39.6±7.2 [10.3 to 56.1] |
Values are presented as n (%), mean±standard deviation, or mean±standard deviation [range].
ECOG, Eastern Cooperative Oncology Group performance status scale; BC, bladder cancer; UTUC, upper urinary tract cancer; BCG IVI, Bacillus Calmette-Guerin intravesical instillation; SAT, subcutaneous adipose tissue; HU, Hounsfield unit; VAT, visceral adipose tissue; MUSCLE, all skeletal muscles; PARA, paraspinal muscles; PSOAS, psoas muscle.